Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression

Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?

(2012) T. E. Hickey et al.   MOLECULAR ENDOCRINOLOGY

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

(2011) Sibylle Loibl et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer

(2011) D. Papadatos-Pastos et al.   ONCOLOGIST

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells

(2010) Miranda P. Ween et al.   INTERNATIONAL JOURNAL OF CANCER

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

(2010) Björn Nodin et al.   Journal of Ovarian Research

Ovarian Low-grade and High-grade Serous Carcinoma

(2009) Russell Vang et al.   ADVANCES IN ANATOMIC PATHOLOGY

Androgen-related expression of G-proteins in ovarian cancer

(2009) L A Sheach et al.   BRITISH JOURNAL OF CANCER

Diverse molecular pathways in ovarian cancer and their clinical significance

(2009) Carmela Ricciardelli et al.   MATURITAS

Precursors of endometrial and ovarian carcinoma

(2009) Robert J. Kurman et al.   VIRCHOWS ARCHIV